NewAmsterdam Pharma Company N.V. Stock Börse Stuttgart
Equities
KH6
NL00150012L7
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
18.1 EUR | -1.09% |
|
+2.23% | +84.85% |
Sales 2024 * | 8.64M 9.32M 12.7M | Sales 2025 * | 6.31M 6.81M 9.28M | Capitalization | 1.67B 1.8B 2.45B |
---|---|---|---|---|---|
Net income 2024 * | -210M -227M -309M | Net income 2025 * | -139M -150M -204M | EV / Sales 2024 * | 193 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 264 x |
P/E ratio 2024 * |
-7.92
x | P/E ratio 2025 * |
-12.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.29% |
Latest transcript on NewAmsterdam Pharma Company N.V.
1 week | +2.23% | ||
Current month | +2.23% | ||
1 month | +8.28% | ||
3 months | -6.15% | ||
6 months | +67.89% | ||
Current year | +84.85% |
![Extreme 17.4](/images/extremecours_fleche.png)
![Extreme 15.5](/images/extremecours_fleche.png)
Date | Price | Change |
---|---|---|
24-07-04 | 18.1 | -1.09% |
24-07-03 | 18.3 | -2.14% |
24-07-02 | 18.7 | +7.47% |
24-07-01 | 17.4 | -2.79% |
24-06-28 | 17.9 | +0.56% |
Delayed Quote Börse Stuttgart, July 04, 2024 at 02:04 am
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.58% | 121B | |
+16.60% | 110B | |
+17.55% | 25.93B | |
-24.33% | 19.27B | |
-19.14% | 16.01B | |
-17.95% | 15.66B | |
-46.81% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- NAMS Stock
- KH6 Stock